US stock · US markets · public data

ZTS

Zoetis Inc · Healthcare

Reference price$75.73Updated according to the public source
P/E12.46
P/B9.96
ROE64.91%
DY 12M2.72%
Net margin—
Net debt/equity—
Market capUS$ 31.3 B
Volume (shares)855,204
SectorHealthcare
Overview

About ZTS

Demonstrações públicas consolidadas + SEC Company Facts

Zoetis Inc (ZTS) is a stock traded in US markets in the Healthcare sector. The consulted sources did not provide revenue, net income or operating cash flow for the latest reported periods.

Available statements: Income statement, Balance sheet, Cash flow. Most recent period in the first statement: 2026.

Distributions

Dividends and distributions · last 12 records

public data
03/21
06/21
03/22
06/22
03/23
06/23
03/24
06/24
03/25
06/25
03/26
06/26
Income in shown records$4.824
DY 12M2.72%
Records shown12
Date / reported periodTypeValue per share/unit
Period ending 2026-06-30Dividendo declarado$0.53
Period ending 2026-03-31Dividendo declarado$0.53
Period ending 2025-06-30Dividendo declarado$0.50
Period ending 2025-03-31Dividendo declarado$0.50
Period ending 2024-06-30Dividendo declarado$0.432
Period ending 2024-03-31Dividendo declarado$0.432

SEC records describe reported fiscal periods, not ex-dividend or payment dates. Only separately reported quarters are shown; missing quarters do not mean zero dividends.

Financials

Income statement, balance sheet and cash flow

Available

Income statement

Account2023202420252026
Revenue$8,544,000,000.00$9,256,000,000.00$9,467,000,000.00—
Net Income$2,344,000,000.00$2,486,000,000.00$2,673,000,000.00—
EPS Diluted$5.07 / share$5.47 / share$6.02 / share—

Balance sheet

Account2023202420252026
Total Assets$14,286,000,000.00$14,237,000,000.00$15,467,000,000.00—
Total Liabilities$9,295,000,000.00$9,467,000,000.00$12,136,000,000.00—
Total Equity$4,991,000,000.00$4,770,000,000.00$3,331,000,000.00—
Long-term Debt$6,564,000,000.00$5,220,000,000.00$9,042,000,000.00—
Current Debt$0.00$1,350,000,000.00$0.00—
Shares Outstanding463,386,716 shares457,867,115 shares447,791,917 shares422,127,709 shares
Cash & Investments————
Dívida Líquida————

Cash flow

Account2023202420252026
Operating Cash Flow$2,353,000,000.00$2,953,000,000.00$2,904,000,000.00—
Capital Expenditures$732,000,000.00$655,000,000.00$621,000,000.00—
Free Cash Flow$1,621,000,000.00$2,298,000,000.00$2,283,000,000.00—
FAQ

Frequently asked questions

What is the price of ZTS?

The reference price available for ZTS is $75.73.

What is the P/E of ZTS?

The P/E ratio of ZTS is 12.46. This compares price with reported earnings per share; a non-positive multiple is not a low positive earnings multiple.

What is the P/B of ZTS?

The P/B of ZTS is 9.96. This compares price with reported book value per share.

What is the ROE of ZTS?

The ROE (Return on Equity) of ZTS is 64.91%. This relates the reported net result to shareholders' equity.

What is the dividend yield of ZTS?

The dividend yield of ZTS is 2.72%. The provider may use annualized dividends; this is not a guaranteed return.

What is the market cap of ZTS?

The market capitalization of ZTS is US$ 31.3 B.

What sector is ZTS in?

ZTS operates in the Healthcare sector.

FundamentalRadar · educational information, not investment advice.